Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

PFIZER, INC.

(PFE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Pfizer : FDA Panel to Vote on Pfizer COVID-19 Shots for Kids; Data Shows Vaccine 90.7% Effective in Children Aged 5 to 11

10/22/2021 | 11:27am EST


© MT Newswires 2021
All news about PFIZER, INC.
02:25pDOJ, SEC Charge Former Immunomedics Finance Chief With Insider Trading
DJ
12:29pWhat COVID-19 vaccine and drug makers have to say about Omicron
RE
09:40aAmazon Web Services, Pfizer Collaborate to Improve New Medicine Development, Distributi..
MT
08:27aViiV - FORTY YEARS ON FROM THE START OF THE HIV EPIDEMIC, NEW DATA REVEALS PEOPLE LIVIN..
AQ
07:06aCovid-19 - Mobile Vaccination Teams Deployed to Weekly Markets, Inland Regions
AQ
05:10aHARVARD UNIVERSITY : Moderna edges out Pfizer vaccine in head-to-head comparison; Large-sc..
AQ
12/01UK Secures 114 Million Additional COVID-19 Shots From Pfizer/BioNTech, Moderna
MT
12/01Hexima Names New Chief Development Officer
MT
12/01U.S. administers 462.3 mln doses of COVID-19 vaccines - CDC
RE
12/01UK agrees deals for 114 million more Moderna and Pfizer COVID-19 doses
RE
More news
Analyst Recommendations on PFIZER, INC.
More recommendations
Financials (USD)
Sales 2021 81 517 M - -
Net income 2021 21 354 M - -
Net Debt 2021 27 873 M - -
P/E ratio 2021 14,1x
Yield 2021 2,89%
Capitalization 307 B 307 B -
EV / Sales 2021 4,11x
EV / Sales 2022 3,87x
Nbr of Employees 78 500
Free-Float 59,3%
Chart PFIZER, INC.
Duration : Period :
Pfizer, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PFIZER, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 22
Last Close Price 54,68 $
Average target price 49,58 $
Spread / Average Target -9,34%
EPS Revisions
Managers and Directors
Albert Bourla Chairman, Chief Executive & Operating Officer
Susan Silbermann President & General Manager-Pfizer Vaccines
Frank A. D'Amelio Chief Financial Officer & EVP-Global Supply
Mikael Dolsten Chief Scientific Officer & Research President
Lidia L. Fonseca Executive VP, Chief Digital & Technology Officer
Sector and Competitors
1st jan.Capi. (M$)
PFIZER, INC.44.21%306 912
JOHNSON & JOHNSON0.44%416 161
ROCHE HOLDING AG18.38%343 323
NOVO NORDISK A/S66.91%247 444
ELI LILLY AND COMPANY47.55%225 859
ABBVIE INC.8.18%204 915